New Accelerator Programme to drive breakthroughs in managing chronic conditions
Pioneer Group, a specialist in life science infrastructure and venture building, has launched a new Accelerator Programme for early-stage life science companies targeting unmet needs in the management of chronic conditions.
Funded by the Innovate UK Biomedical Catalyst, in collaboration with the Medical Research Council, the Accelerator has been designed to support UK start-ups in the initial phases of their development.